188 related articles for article (PubMed ID: 20518849)
1. Ischemia induced peroxynitrite dependent modifications of cardiomyocyte MLC1 increases its degradation by MMP-2 leading to contractile dysfunction.
Polewicz D; Cadete VJ; Doroszko A; Hunter BE; Sawicka J; Szczesna-Cordary D; Light PE; Sawicki G
J Cell Mol Med; 2011 May; 15(5):1136-47. PubMed ID: 20518849
[TBL] [Abstract][Full Text] [Related]
2. Ischemia/reperfusion-induced myosin light chain 1 phosphorylation increases its degradation by matrix metalloproteinase 2.
Cadete VJ; Sawicka J; Jaswal JS; Lopaschuk GD; Schulz R; Szczesna-Cordary D; Sawicki G
FEBS J; 2012 Jul; 279(13):2444-54. PubMed ID: 22564771
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of MMP-2 expression with siRNA increases baseline cardiomyocyte contractility and protects against simulated ischemic reperfusion injury.
Lin HB; Cadete VJ; Sra B; Sawicka J; Chen Z; Bekar LK; Cayabyab F; Sawicki G
Biomed Res Int; 2014; 2014():810371. PubMed ID: 25147815
[TBL] [Abstract][Full Text] [Related]
4. Combined subthreshold dose inhibition of myosin light chain phosphorylation and MMP-2 activity provides cardioprotection from ischaemic/reperfusion injury in isolated rat heart.
Cadete VJ; Sawicka J; Bekar LK; Sawicki G
Br J Pharmacol; 2013 Sep; 170(2):380-90. PubMed ID: 23822644
[TBL] [Abstract][Full Text] [Related]
5. Cardiac dysfunction in an animal model of neonatal asphyxia is associated with increased degradation of MLC1 by MMP-2.
Doroszko A; Polewicz D; Sawicka J; Richardson JS; Cheung PY; Sawicki G
Basic Res Cardiol; 2009 Nov; 104(6):669-79. PubMed ID: 19452190
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of matrix metalloproteinases prevents peroxynitrite-induced contractile dysfunction in the isolated cardiac myocyte.
León H; Baczkó I; Sawicki G; Light PE; Schulz R
Br J Pharmacol; 2008 Feb; 153(4):676-83. PubMed ID: 18071296
[TBL] [Abstract][Full Text] [Related]
7. Subthreshold nitric oxide synthase inhibition improves synergistic effects of subthreshold MMP-2/MLCK-mediated cardiomyocyte protection from hypoxic injury.
Bil-Lula I; Lin HB; Biały D; Wawrzyńska M; Diebel L; Sawicka J; Woźniak M; Sawicki G
J Cell Mol Med; 2016 Jun; 20(6):1086-94. PubMed ID: 26992120
[TBL] [Abstract][Full Text] [Related]
8. Titin is a target of matrix metalloproteinase-2: implications in myocardial ischemia/reperfusion injury.
Ali MA; Cho WJ; Hudson B; Kassiri Z; Granzier H; Schulz R
Circulation; 2010 Nov; 122(20):2039-47. PubMed ID: 21041693
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of MMP-2 expression affects metabolic enzyme expression levels: proteomic analysis of rat cardiomyocytes.
Lin HB; Sharma K; Bialy D; Wawrzynska M; Purves R; Cayabyab FS; Wozniak M; Sawicki G
J Proteomics; 2014 Jun; 106():74-85. PubMed ID: 24769238
[TBL] [Abstract][Full Text] [Related]
10. Degradation of cardiac myosin light chain kinase by matrix metalloproteinase-2 contributes to myocardial contractile dysfunction during ischemia/reperfusion.
Gao L; Zheng YJ; Gu SS; Tan JL; Paul C; Wang YG; Yang HT
J Mol Cell Cardiol; 2014 Dec; 77():102-12. PubMed ID: 25451385
[TBL] [Abstract][Full Text] [Related]
11. Synergistic effect of inhibitors of MMPs and ROS-dependent modifications of contractile proteins on protection hearts subjected to oxidative stress.
Sawicki G
Curr Pharm Des; 2014; 20(9):1345-8. PubMed ID: 23978100
[TBL] [Abstract][Full Text] [Related]
12. Degradation of myosin light chain in isolated rat hearts subjected to ischemia-reperfusion injury: a new intracellular target for matrix metalloproteinase-2.
Sawicki G; Leon H; Sawicka J; Sariahmetoglu M; Schulze CJ; Scott PG; Szczesna-Cordary D; Schulz R
Circulation; 2005 Jul; 112(4):544-52. PubMed ID: 16027249
[TBL] [Abstract][Full Text] [Related]
13. Junctophilin-2 is a target of matrix metalloproteinase-2 in myocardial ischemia-reperfusion injury.
Chan BYH; Roczkowsky A; Cho WJ; Poirier M; Lee TYT; Mahmud Z; Schulz R
Basic Res Cardiol; 2019 Sep; 114(6):42. PubMed ID: 31506724
[TBL] [Abstract][Full Text] [Related]
14. Peroxynitrite-induced myocardial injury is mediated through matrix metalloproteinase-2.
Wang W; Sawicki G; Schulz R
Cardiovasc Res; 2002 Jan; 53(1):165-74. PubMed ID: 11744025
[TBL] [Abstract][Full Text] [Related]
15. Matrix metalloproteinase-2 degrades the cytoskeletal protein alpha-actinin in peroxynitrite mediated myocardial injury.
Sung MM; Schulz CG; Wang W; Sawicki G; Bautista-López NL; Schulz R
J Mol Cell Cardiol; 2007 Oct; 43(4):429-36. PubMed ID: 17854826
[TBL] [Abstract][Full Text] [Related]
16. Matrix metalloproteinase-2 is activated during ischemia/reperfusion in a model of myocardial infarction.
Cadete VJ; Arcand SA; Chaharyn BM; Doroszko A; Sawicka J; Mousseau DD; Sawicki G
Can J Cardiol; 2013 Nov; 29(11):1495-503. PubMed ID: 23770015
[TBL] [Abstract][Full Text] [Related]
17. Tyrosine nitration of voltage-dependent anion channels in cardiac ischemia-reperfusion: reduction by peroxynitrite scavenging.
Yang M; Camara AK; Wakim BT; Zhou Y; Gadicherla AK; Kwok WM; Stowe DF
Biochim Biophys Acta; 2012 Nov; 1817(11):2049-59. PubMed ID: 22709907
[TBL] [Abstract][Full Text] [Related]
18. Klotho Protein Decreases MMP-Mediated Degradation of Contractile Proteins during Ischaemia/Reperfusion Injury to the Cardiomyocytes.
Olejnik A; Krzywonos-Zawadzka A; Banaszkiewicz M; Bil-Lula I
Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555091
[TBL] [Abstract][Full Text] [Related]
19. Nuclear matrix metalloproteinase-2 in the cardiomyocyte and the ischemic-reperfused heart.
Baghirova S; Hughes BG; Poirier M; Kondo MY; Schulz R
J Mol Cell Cardiol; 2016 May; 94():153-161. PubMed ID: 27079252
[TBL] [Abstract][Full Text] [Related]
20. Role of iNOS-derived reactive nitrogen species and resultant nitrative stress in leukocytes-induced cardiomyocyte apoptosis after myocardial ischemia/reperfusion.
Wang XL; Liu HR; Tao L; Liang F; Yan L; Zhao RR; Lopez BL; Christopher TA; Ma XL
Apoptosis; 2007 Jul; 12(7):1209-17. PubMed ID: 17333318
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
